CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

Clinical trials for CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) explained in plain language.

Never miss a new study

Get alerted when new CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) trials appear

Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Tracking the staying power of a leukemia drug

Knowledge-focused Ongoing

This study aims to understand how long patients with chronic lymphocytic leukemia (CLL) continue taking the drug acalabrutinib in real-world German clinics. It will follow 137 patients for up to two years to see who stays on the treatment and why some might stop. The goal is to g…

Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:40 UTC

CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

Get alerted when new CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) trials appear

Tracking the staying power of a leukemia drug